ImmunityBio, Inc.
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulato…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
ImmunityBio, Inc. has no obligation with a government/award agency.
Latest Obligations
- No trends presentable at the moment.
Spending By Type
ImmunityBio, Inc. can't present spending by time.
Contract Analysis
Palmy tracks high-doted primary awards as well as their sub contracts on a regular basis.
This empowers you to dive deeper to unveil recent changes, risks and products/services ImmunityBio, Inc.
offers.
There are no contract award details available for ImmunityBio, Inc.